United States-based MCI Diagnostic Center, a Service-Disabled Veteran-Owned small business that provides national laboratory testing and diagnostics in all 50 states, has launched a new laboratory in Dallas, Texas, it was reported on Friday.
The company is an SBA HUBZone certified and accredited by CLIA, CAP, COLA and FDA.
At the laboratory's official opening, Colleen Payne-Nabors MCI Diagnostic Center COO, said, 'We are providing a wonderful service in this time of need for our country. I thank each of you for coming and supporting the grand opening of MCI and we look forward to a long and healthy relationship on the other side of COVID-19.'
Privo Technologies reports progress in oral cancer trial
BeOne Medicines' sonrotoclax receives FDA Breakthrough Therapy Designation for MCL
Ascletis selects once-monthly SQ GLP-1R/GIPR dual peptide agonist, ASC35, for clinical development
Celltrion's biosimilar EYDENZELT (aflibercept-boav) approved by US FDA
Rigel Pharmaceuticals begins dose expansion phase of R289 study in lower-risk MDS
Precision NeuroMed's glioblastoma multiforme treatment granted FDA Orphan Drug Designation
Merck completes acquisition of Verona Pharma to expand cardio-pulmonary portfolio
Oxford Biomedica expands US operations with acquisition of viral vector facility in North Carolina
DarioHealth and OneStep partner to integrate fall risk technology into digital health platform
Ananda Pharma achieves key Phase 1 milestone for MRX1 CBD program
Alvotech and Advanz Pharma announce EMA acceptance of AVT23 marketing application